Description

LifeTech Scientific Corporation, an investment holding company founded in 1999 and based in Shenzhen, People's Republic of China, focuses on the research, production, and distribution of interventional medical devices. These advanced technologies are utilized in treating ailments of the cardiovascular and peripheral vascular systems. The company's operations are structured across three primary divisions: Structural Heart Diseases, Peripheral Vascular Diseases, and Cardiac Pacing and Electrophysiology. Its extensive product range features innovative solutions such as the LAmbre left atrial appendage closure systems, a variety of VSD occluders (including CeraFlex, Cera, Heart, and Konara-MF), and Ankura stent graft systems for both thoracic and abdominal aortic aneurysms. LifeTech also provides critical auxiliary components like Fustar steerable and SteerEase introducers, in addition to devices such as Aegisy vena cava filters, Cera vascular plug systems, AcuMark sizing balloons, LawMax dilators, SeQure snare systems, and pacemakers. Beyond its core medical device activities, the corporation engages in biomedical research and development, the manufacturing and trade of various materials (including those related to hemp), internal staff training and management, investor information consulting, and a suite of technical, advisory, and technological services. LifeTech Scientific maintains a broad international presence, with business activities spanning Mainland China, India, the wider Asian region, Europe, South America, Africa, and other global territories.